mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.7 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
-0.055 |
0.7 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
AP-24534 |
FIMM |
pan-cancer |
AAC |
-0.055 |
0.8 |